 is necessary
to ensure that elevated risk of delayed or poor wound
healing and amputation is identiﬁed early so this can
be addressed without treatment delay.
Despite the severity of the outcomes of PAD in people with diabetes, and particularly for those with DFU,
there are few practice guidelines that speciﬁcally
address the diagnosis and management of PAD in
this population. Formulating recommendations for
this speciﬁc population should take into account the
multisystem